- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04443231
Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
June 22, 2020 updated by: Peking University Third Hospital
To observe the retinal microvascular alteration during 3 months follow-up after Implantable Collamer Lens (ICL) operation in moderate and high myopia patients using quantitative optical coherence tomography angiography (OCTA) analysis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study object is moderate and high myopia patients, underwent ICL implantation.
OCTA was used to image the superficial and deep retinal vascular plexuses before ICL implantation surgery and at 3 months follow-up.
OCTA images were corrected for magnification, skeletonized, separated the large vessels and partitioned.
Retinal microvascular density was measured by using fractal dimension analysis.
The aim of this study was to uncover potential retinal vascular network alterations induced by ICL implantation surgery.
Study Type
Observational
Enrollment (Actual)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Peking University Third Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Moderate and high myopia patients, underwent ICL implantation surgery at the Department of Ophthalmology, Peking University Third Hospital
Description
Inclusion Criteria:
- 18 to 45 years old;
- Binocular myopia, with a refraction of greater than -3 diopters (D);
- anterior chamber depth (ACD, measured from the endothelium to the crystalline lens) > 2.8 mm;
- corneal endothelial cell count (cECC) ≥ 2000 cells/mm2;
- stable refraction at least 1 year before surgery;
- unsatisfactory vision with contact lenses or spectacles.
Exclusion Criteria:
- history of intraocular surgery
- other ocular pathology (uveitis, glaucoma, cataract, keratoconus, severe dry eye, etc.)
- other serious systemic disease (diabetes, uncontrolled hypertension, severe hyperthyroidism, etc.).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retinal microvessels density
Time Frame: 3 months postoperatively
|
Retinal microvessels density was measured with fractal dimension analysis by using Matalb (The Mathworks, Inc., Natick, MA, USA)
|
3 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Best corrected visual acuity
Time Frame: 3 months postoperatively
|
BCVA was evaluated by decimal Snellen and converted to the logarithm of the minimum angle of resolution (logMAR) for statistical analysis.
|
3 months postoperatively
|
Mean refractive spherical equivalent
Time Frame: 3 months postoperatively
|
MRSE = Spherical power + 0.5 * Cylindrical power
|
3 months postoperatively
|
Intraocular pressure
Time Frame: 3 months postoperatively
|
The IOP was measured using a non-contact tonometer (CT-80; Topcon, Tokyo, Japan).
|
3 months postoperatively
|
Vault
Time Frame: 3 months postoperatively
|
The central vault of the ICL (distance from posterior surface of ICL to the crystalline lens) was measured using Optical Coherence Tomography (Visante; Carl Zeiss Meditec, Jena, Germany)
|
3 months postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Hong Qi, PhD, MD, Peking University Third Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sanders DR, Doney K, Poco M; ICL in Treatment of Myopia Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia: three-year follow-up. Ophthalmology. 2004 Sep;111(9):1683-92. doi: 10.1016/j.ophtha.2004.03.026.
- Yang Y, Wang J, Jiang H, Yang X, Feng L, Hu L, Wang L, Lu F, Shen M. Retinal Microvasculature Alteration in High Myopia. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6020-6030. doi: 10.1167/iovs.16-19542.
- Li M, Yang Y, Jiang H, Gregori G, Roisman L, Zheng F, Ke B, Qu D, Wang J. Retinal Microvascular Network and Microcirculation Assessments in High Myopia. Am J Ophthalmol. 2017 Feb;174:56-67. doi: 10.1016/j.ajo.2016.10.018. Epub 2016 Nov 4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2018
Primary Completion (Actual)
October 1, 2019
Study Completion (Actual)
October 1, 2019
Study Registration Dates
First Submitted
March 17, 2020
First Submitted That Met QC Criteria
June 22, 2020
First Posted (Actual)
June 23, 2020
Study Record Updates
Last Update Posted (Actual)
June 23, 2020
Last Update Submitted That Met QC Criteria
June 22, 2020
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- tch0101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent
-
University of CoimbraRecruitingAdolescent Behavior | Adolescent - Emotional ProblemPortugal
-
National Institute of Environmental Health Sciences...RecruitingAdolescent Health | Pediatrics | Adolescent Development | Reproductive Physiological ProcessesUnited States
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD); SoLaHmoCompletedAdolescent Health | Adolescent School Connectedness | Community Based Participatory Research MethodsUnited States
-
World Health OrganizationLondon School of Hygiene and Tropical Medicine; University of Ghana; Biomedical... and other collaboratorsRecruitingHealth-Related Behavior | Adolescent Behavior | Adolescent Development | Health Care Seeking BehaviorGhana, Tanzania, Zimbabwe
-
Friends Research Institute, Inc.Conrad N. Hilton FoundationCompletedAdolescent Behavior | Adolescent Health ServicesUnited States
-
Aksaray UniversityEskisehir Osmangazi UniversityRecruiting
-
Eastern Mediterranean UniversityRecruiting
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of KlagenfurtCardiff University; Medical University of Vienna; Bielefeld University; Institute... and other collaboratorsRecruitingParent-Child Relations | Parenting | Adolescent Behavior | Adolescent - Emotional Problem | Psychological Well-BeingMoldova, Republic of, North Macedonia
Clinical Trials on Optical Coherence Tomography Angiography
-
Khon Kaen UniversityRecruitingRetinal Vascular | Twin Pregnancy, Antepartum Condition or Complication | Choroidal EffusionThailand
-
Kasr El Aini HospitalCompletedTractional Retinal Detachment | Diabetic Vitreous HemorrhageEgypt
-
Khon Kaen UniversityNot yet recruiting
-
Singapore National Eye CentreRecruitingLong-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)Polypoidal Choroidal VasculopathySingapore
-
Hospital da Luz, PortugalRecruitingSeptic ShockPortugal
-
University of British ColumbiaRecruitingDiabetes Mellitus | Diabetic RetinopathyCanada
-
Omar SaidCompletedNon-arteritic Ischemic Optic NeuropathyEgypt
-
Balwantray ChauhanActive, not recruiting
-
Semmelweis UniversityCompletedOptical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion (RAO-OCTA)Retinal Artery OcclusionHungary
-
Federico II UniversityCompleted